Hindustan Bio Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Hindustan Bio Sciences Ltd · Outcome · 31 Oct 2026, 7:45 pm
Hindustan Bio Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 82.2 ■ EBITDA: 28.3 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 34.4 ■ PAT: 31.0 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 0.30 (Loss to Profit YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Hindustan Bio Sciences Ltd
- Mr. Shailendra Vyas (Membership No. 77193) has resigned from position of Company Secretary and Compliance officer with effect from closer of business hours of 31-10-2026 · 31 Oct 2026
- Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Un-audited Financial .... · 31 Oct 2026
- We would like to inform you that the 34th Annual General Meeting of the Company held on 30th September 2026 at the registered office of the company · 30 Sept 2026
- We would like to inform you that the 34th Annual General Meeting of the company held on 30th September 2026 at the register officer of the Company · 30 Sept 2026
- Proceedings of 34th Annual General Meeting Held on 30-09-2026 · 30 Sept 2026
- With Reference to the subject cited please find the 34th Annual Report along with the intimation for the financial year 2025-26 · 04 Sept 2026
- Submission of 34th Annual Report including the notice of Annual General Meeting for the financial year 2025-26 under regulation 34 of SEBI (LODR), Regulation 2015 · 03 Sept 2026
- Outcome of the Board Meeting held on 31-08-2026 · 31 Aug 2026
